Skip to main content
GlaxoSmithKline PLC logo

GlaxoSmithKline PLC — Investor Relations & Filings

Ticker · GSK ISIN · GB00BN7SWP63 LEI · 5493000HZTVUYLO1D793 IL Manufacturing
Open in API
Filings indexed 7,016 across all filing types
Latest filing 2025-11-07 Regulatory Filings
Country GB United Kingdom
Listing IL GSK

About GlaxoSmithKline PLC

https://www.gsk.com/en-gb/

GSK plc is a global biopharmaceutical company that unites science, technology, and talent to research, develop, and manufacture medicines and vaccines. The company focuses on preventing and treating disease across four primary therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Its portfolio consists of specialty medicines and vaccines aimed at addressing significant global health needs. GSK's strategy centers on leveraging its research and development capabilities to deliver new health solutions.

Recent filings

Filing Released Lang Actions
TRANSACTION IN OWN SHARES
Regulatory Filings
2025-11-07 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is a regulatory announcement from GSK plc regarding the purchase of its own shares (share buyback) on the London Stock Exchange and other venues. It provides detailed transaction data, including dates, prices, and volumes, which is characteristic of a 'Transaction in Own Shares' filing. It does not fit the criteria for a report publication announcement as it is the primary disclosure of the transaction itself.
2025-11-07 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2025-11-06 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from GSK plc regarding the purchase of its own shares (a share buyback program). It provides specific details on the number of shares purchased, the price paid, the trading venues, and the impact on treasury shares and total voting rights. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS).
2025-11-06 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2025-11-05 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from GSK plc regarding the purchase of its own shares as part of a share buyback program. It includes detailed tables of transaction dates, prices, venues, and volumes, which is characteristic of a 'Transaction in Own Shares' filing. It explicitly mentions 'Transaction in own shares' in the header and provides the required regulatory disclosure information.
2025-11-05 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.